Penserra Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $145K | Sell |
6,021
-1,606
| -21% | -$38.7K | ﹤0.01% | 684 |
|
2025
Q1 | $192K | Sell |
7,627
-15,793
| -67% | -$398K | ﹤0.01% | 745 |
|
2024
Q4 | $620K | Buy |
23,420
+15,006
| +178% | +$397K | 0.01% | 520 |
|
2024
Q3 | $243K | Buy |
8,414
+2,772
| +49% | +$80.1K | 0.01% | 680 |
|
2024
Q2 | $158K | Buy |
5,642
+5,183
| +1,129% | +$145K | ﹤0.01% | 766 |
|
2024
Q1 | $12K | Sell |
459
-25,666
| -98% | -$671K | ﹤0.01% | 916 |
|
2023
Q4 | $751K | Sell |
26,125
-5,486
| -17% | -$158K | 0.01% | 430 |
|
2023
Q3 | $1.05M | Sell |
31,611
-4,951
| -14% | -$164K | 0.02% | 351 |
|
2023
Q2 | $1.34M | Buy |
36,562
+35,044
| +2,309% | +$1.28M | 0.03% | 340 |
|
2023
Q1 | $61K | Sell |
1,518
-11,782
| -89% | -$473K | ﹤0.01% | 833 |
|
2022
Q4 | $680K | Buy |
+13,300
| New | +$680K | 0.01% | 471 |
|
2022
Q2 | – | Sell |
-17,916
| Closed | -$926K | – | 1476 |
|
2022
Q1 | $926K | Buy |
17,916
+11,476
| +178% | +$593K | 0.02% | 414 |
|
2021
Q4 | $380K | Buy |
+6,440
| New | +$380K | 0.01% | 565 |
|
2020
Q4 | – | Sell |
-2,353
| Closed | -$81K | – | 1104 |
|
2020
Q3 | $81K | Sell |
2,353
-223
| -9% | -$7.68K | ﹤0.01% | 532 |
|
2020
Q2 | $79K | Sell |
2,576
-428
| -14% | -$13.1K | ﹤0.01% | 625 |
|
2020
Q1 | $106K | Buy |
3,004
+318
| +12% | +$11.2K | 0.01% | 556 |
|
2019
Q4 | $95K | Buy |
2,686
+518
| +24% | +$18.3K | 0.01% | 615 |
|
2019
Q3 | $73K | Sell |
2,168
-28,332
| -93% | -$954K | 0.01% | 612 |
|
2019
Q2 | $1.25M | Buy |
30,500
+3,025
| +11% | +$124K | 0.1% | 195 |
|
2019
Q1 | $1.06M | Sell |
27,475
-6,032
| -18% | -$232K | 0.08% | 213 |
|
2018
Q4 | $1.39M | Sell |
33,507
-9,449
| -22% | -$391K | 0.13% | 159 |
|
2018
Q3 | $1.8M | Buy |
+42,956
| New | +$1.8M | 0.11% | 130 |
|